Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data

by Jingsong He, Donghua He, Xiaoyan Han, Gaofeng Zheng, Guoqing Wei, Yi Zhao, Yang Yang, Wenjun Wu, Jiaping Fu, Lihong Shou, Hongwei Kong, He Huang, Zhen Cai
Published 2020-12-01

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.

by Jingsong He, Li Yang, Xiaoyan Han, Gaofeng Zheng, Weiyan Zheng, Guoqing Wei, Wenjun Wu, Xiujin Ye, Jimin Shi, Wanzhuo Xie, Li Li, Jie Zhang, Weijia Huang, Yi Zhao, He Huang, Xuejin Zhang, Jiaping Fu, Zhen Cai
Published 2014-01-01